PUBLISHER: GlobalData | PRODUCT CODE: 1410861
PUBLISHER: GlobalData | PRODUCT CODE: 1410861
PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on PTCA Balloon Catheters market for the year 2020 and beyond. Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps in restoring blood flow in the blocked coronary arteries by opening them. PTCA procedure helps in eliminating the requirement of open heart surgery. This procedure can only be performed with the help of PTCA balloons catheters which help in opening the blocked coronary artery by compressing the plague as well as delivering stents in case of stenting. These catheters have an attached balloon at tip of the catheters.
Types of PTCA balloon catheters include Standard Balloon Catheters, Cutting and Scoring Balloon Catheters and Drug-Eluting Balloon Catheters. Percutaneous transluminal coronary angioplasty (PTCA) has become the basic interventional modality because of its minimally invasive nature.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed PTCA Balloon Catheters and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Meril Life Sciences Pvt Ltd, Teleflex Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable